Metraipolis › archive › dc_a25f4c151bd2

Atypical cadherin CELSR2 acts as a therapeutic target for glioma through WNT3A/β-catenin signaling — Europe PMC PMID:41184253

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41184253
DOI
10.1038/s41419-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-08T19:50:07.760Z
SHA-256 of the archived text
e9637f781cfc3707aaa94595785e9ca51beaa2dab4b30cbd3e5cb82c2cff70d5
Stable URL of this page
https://metraipolis.com/documento/dc_a25f4c151bd2

How to cite

Atypical cadherin CELSR2 acts as a therapeutic target for glioma through WNT3A/β-catenin signaling — Europe PMC PMID:41184253 — Europe PMC (en), https://europepmc.org/article/MED/41184253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a25f4c151bd2 (Metraipolis archive dc_a25f4c151bd2, sha256 e9637f781cfc3707aaa94595785e9ca51beaa2dab4b30cbd3e5cb82c2cff70d5)
BibTeX
@misc{dca25f4c151bd2,
  title = {Atypical cadherin CELSR2 acts as a therapeutic target for glioma through WNT3A/β-catenin signaling — Europe PMC PMID:41184253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41184253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a25f4c151bd2; sha256 e9637f781cfc3707aaa94595785e9ca51beaa2dab4b30cbd3e5cb82c2cff70d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41184253. Agents can read the archived copy with the MCP tool read_document.